الصفحات

أعلان الهيدر

a

Wednesday, November 11, 2015

Mesothelioma Law Firm

Mesothelioma Law Firm :
For over three decades, the mesothelioma law firm of Early, Lucarelli, Sweeney and Meisenkothen has limited its practice to asbestos litigation. In that time,  helped thousands of mesothelioma victims get the financial compensation they deserved for injuries they sustained from asbestos products made and sold by negligent asbestos companies
Choosing a good mesothelioma lawyer is imperative to ensuring that you will be awarded the highest settlement dollars for your case. 
If there’s one thing we know about mesothelioma treatment, it’s this: we continue to be challenged to find the most effective way of treating the disease.
Despite years of research since mesothelioma was first identified, it’s still difficult to identify the best approach to treating the disease, says David Rice, MD, a cardiothoracic surgeon and nationally known mesothelioma expert who practices at the MD Anderson Cancer Center in Houston, TX.
The very rareness of the cancer — only about 3,000 people a year are diagnosed in the United States—makes it difficult to run the kind of research studies needed to compare treatments and determine the ideal therapy at each stage of the disease. “There isn’t a lot of evidence-based science in this disease,” Dr. Rice admits. So when his patients ask him what the best treatment is for the disease, he tells them what we tell you in this section, adding that “we don’t have a reliable cure for mesothelioma.” Thus, a major goal of treatment is to reduce pain and suffering and prolong a patient’s life as long as possible while providing them with the highest quality of life possible.
Choosing the right mesothelioma doctor is an important first step in planning for treatment.
There are a number of mesothelioma doctors practicing in specialized clinics throughout the country. Each of these cancer specialists has an acute knowledge of the behavior and pathology of malignant mesothelioma and its treatment. It is likely that if you are diagnosed with mesothelioma, you will be referred by your personal physician to a larger scale comprehensive cancer center.
Important considerations in determining a mesothelioma treatment plan include the cancer stage, primary site affected and cell type. Treatment options also depend on whether the cancer is localized to the chest or has spread to the chest wall, diaphragm, or lymph nodes as well as your age and overall health. Recommended treatment plans will also vary based on available resources and any ongoing clinical trials at the cancer center where you’re being treated. Learn more about finding a doctor here. You should be prepared when you meet with your doctor by being ready to ask these questions.
Conventional treatments for mesothelioma involve surgery, chemotherapy, and radiation therapy.
As with most solid tumors, doctors turn to surgery, radiation and chemotherapy to manage mesothelioma. When exploring the various treatment options available with your doctor it is important to be informed about the risk and benefits of each one before making a final decision.
Surgery
Only about 1 in 5 patients with metastatic pleural mesothelioma undergo surgery. There are two main surgeries: pleurectomy/decortication, in which the surgeon tries to remove as much of the tumor from around the lung as possible, and the more radical extrapleural pneumonectomy, in which the lung itself is removed.
Much debate exists as to which surgery is more effective, although studies show that most long-term survivors have undergone some form of surgery. Studies have found that pneumonectomy followed by radiation prevents tumor recurrence in the chest in 80 to 85 percent of patients.
However, it is a long, intensive operation with a 55 percent complication rate and a 3 percent risk of death, higher in some institutions. Therefore, this surgery is only performed for patients with a reasonably good prognosis, when it doesn’t appear that the cancer has spread outside the chest.
Patients best suited for pneumonectomy are younger, with the epithelial form of the disease, no obvious lymph node involvement, and are otherwise healthy enough to withstand the rigor of the procedure.
Pleurectomy/decortication has a higher failure rate, with the tumor recurring in the chest cavity 50 to 80 percent of the time. However, that rate may change with improved radiotherapy techniques. The reason for the high recurrence is that it’s difficult to completely remove the tumor without removing the lung.
However, there is no difference in survival rates between the two surgeries. Part of the reason is that the cancer has often spread to other parts of the body by the time it is diagnosed even if it appears to be confined to the chest.
In the end, part of the debate around the value of surgery is whether many patients who undergo surgery do better because the patients offered it are the very patients most likely to do well regardless of treatment, since surgery tends to be offered far more readily to younger, fit patients with earlier stage disease. There is no randomized trial evidence that demonstrates a significant benefit to surgery over non-surgical management of mesothelioma.

No comments:

Post a Comment

Powered by Blogger.